| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1991 Oxford University Press
research-article |
Modelling the Analysis of Breast Cancer Screening Programmes: Sensitivity, Lead Time and Predictive Value in the Florence District Programme (19751986)

*Center for the Study and Prevention of Cancer Epidemiology Unit V. le Volta, 171, 50125 Florence, Italy
MRC Biostatistics Unit Cambridge, UK
Statistical indicators of early efficacy were estimated in the Florence District Programme where breast cancer screening has been carried out since 1970. Analysis of screen-detected and interval cancer data by means of statistical modelling using GLIM allowed us to estimate the mean sojourn time (1.91 and 3.97 years in 4049 and 5069 year old women respectively), sensitivity (about 90% for those aged 5069) and predictive value at the prevalence screening test (about 100%). Results were compared with estimates of the same parameters in the Health Insurance Plan and Swedish Two County studies.
Revised 1 April 1991
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. W. Duffy, I. D. Nagtegaal, M. Wallis, F. H. Cafferty, N. Houssami, J. Warwick, P. C. Allgood, O. Kearins, N. Tappenden, E. O'Sullivan, et al. Correcting for Lead Time and Length Bias in Estimating the Effect of Screen Detection on Cancer Survival Am. J. Epidemiol., July 1, 2008; 168(1): 98 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sihto, J. Lundin, T. Lehtimaki, M. Sarlomo-Rikala, R. Butzow, K. Holli, L. Sailas, V. Kataja, M. Lundin, T. Turpeenniemi-Hujanen, et al. Molecular Subtypes of Breast Cancers Detected in Mammography Screening and Outside of Screening Clin. Cancer Res., July 1, 2008; 14(13): 4103 - 4110. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Weedon-Fekjaer, B. H Lindqvist, L. J Vatten, O. O Aalen, and S. Tretli Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening J Med Screen, June 1, 2008; 15(2): 83 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mandelblatt, C. B. Schechter, W. Lawrence, B. Yi, and J. Cullen Chapter 8: The SPECTRUM Population Model of the Impact of Screening and Treatment on U.S. Breast Cancer Trends From 1975 to 2000: Principles and Practice of the Model Methods J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 47 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hamashima, T. Sobue, Y. Muramatsu, H. Saito, N. Moriyama, and T. Kakizoe Comparison of Observed and Expected Numbers of Detected Cancers in the Research Center for Cancer Prevention and Screening Program Jpn. J. Clin. Oncol., May 1, 2006; 36(5): 301 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Mandelblatt, C. B. Schechter, K. R. Yabroff, W. Lawrence, J. Dignam, P. Muennig, Y. Chavez, J. Cullen, and M. Fahs Benefits and Costs of Interventions to Improve Breast Cancer Outcomes in African American Women J. Clin. Oncol., July 1, 2004; 22(13): 2554 - 2566. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.J. van Klaveren, J.D.F. Habbema, J.H. Pedersen, H.J. de Koning, M. Oudkerk, and H.C. Hoogsteden Lung cancer screening by low-dose spiral computed tomography Eur. Respir. J., November 1, 2001; 18(5): 857 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shen and M. Zelen Screening Sensitivity and Sojourn Time From Breast Cancer Early Detection Clinical Trials: Mammograms and Physical Examinations J. Clin. Oncol., August 1, 2001; 19(15): 3490 - 3499. [Abstract] [Full Text] [PDF] |
||||






